The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to ...

Panelists discuss how transitioning patients from intravenous (IV) to subcutaneous (SubQ) therapies demands a coordinated, multidisciplinary approach—integrating clinical judgment, electronic medical ...

I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie has launched an Expanded Access Program ...

The FDA has approved Gammagard Liquid ERC as a replacement therapy for PI in adult and pediatric patients 2 years of age and older.

The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment INDIANAPOLIS, ...

Panelists discuss how the rise of patient awareness around subcutaneous (SubQ) therapies calls for empathetic, evidence-based education, shared decision-making, and seamless system integration to ...

Shefali Jariwala died following a suspected cardiac arrest.

At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.

Morquio Syndrome, or Mucopolysaccharidosis Type IV (MPS IV), is a rare genetic disorder causing glycosaminoglycans (GAGs) buildup due to enzyme deficiencies, leading to severe skeletal and organ ...